CV Sciences, Inc. has recently disclosed significant stock acquisitions by its major shareholder, Charlie E. Cheever III. The transactions, reported in a recent SEC filing, indicate a strong vote of confidence in the company's future prospects.

On November 17 and 18, 2026, Cheever acquired a total of 2,030,711 shares of common stock, with each share priced at $0.01. Following these transactions, Cheever now owns a total of 34,120,348 shares in CV Sciences.

Background

CV Sciences, Inc. operates within the pharmaceutical preparations industry, classified under SIC 2834. The company is publicly traded on the OTC exchange under the ticker symbol CVSI. Recent filings indicate that CV Sciences is a smaller reporting company and a non-accelerated filer.

What the Filing Says

"On November 17, 2026, Charlie E. Cheever III acquired 1,628,093 shares, and on November 18, 2026, he acquired an additional 402,618 shares of common stock."

Impact

The acquisitions by Cheever, who is a ten percent owner of the company, may influence both investor sentiment and market dynamics for CV Sciences. As a significant shareholder, his actions are likely to be closely monitored by other investors and analysts in the pharmaceutical preparations industry.

What's Next

The filing does not say what happens next.